4 results match your criteria: "The Ohio State University Department of Neurology[Affiliation]"
Epilepsy Behav
September 2018
The Ohio State University Department of Neurology, 395 W 12th St, 7th floor, Columbus, OH 43201, United States of America. Electronic address:
Objective: The study aimed to evaluate adult patient or caregiver feelings and viewpoints about sudden unexpected death in epilepsy (SUDEP) awareness.
Background: The decision to discuss SUDEP with patients and families has created much debate. Many healthcare providers (HCPs) are hesitant to discuss SUDEP because of the perception of evoking unnecessary fear in patients while others argue that informing patients about SUDEP may enhance patient compliance, improve seizure control, and aid in saving lives.
Orphanet J Rare Dis
February 2017
Nationwide Children's Hospital, Columbus, OH, USA.
Background: Cardiomyopathy is a leading cause of morbidity and mortality in boys with Duchenne muscular dystrophy (DMD). We recently showed in a 12-month double-blind randomized controlled trial that adding eplerenone to background medical therapy was cardioprotective in this population. The objective of this study was to evaluate the safety and efficacy of longer-term eplerenone therapy in boys with DMD.
View Article and Find Full Text PDFNeurol Clin Pract
October 2013
The Ohio State University Department of Neurology, Columbus.
Preliminary studies have suggested that a high salt diet may play a role in the development of autoimmune disease and possibly multiple sclerosis (MS). Promising clinical trial results for 2 new therapies for MS have been reported. Dimethyl fumarate, also known by its investigational name BG-12, became the third oral disease-modifying therapy for MS to be Food and Drug Administration (FDA)-approved in March 2013.
View Article and Find Full Text PDFSeizure
July 2007
The Ohio State University Department of Neurology, 1654 Upham Drive Columbus, OH 43210, USA.
In the neurology literature it is well established that anti-epileptic drugs (AEDs) lead to bone loss (osteopenia and osteoporosis). Several large epidemiologic studies have found twice the fracture rate in persons with epilepsy compared to the non-epilepsy population. While an increasing level of awareness for preventative measures and screening by neurologists and primary care physicians are recommended, so far no one has attempted to address how knowledge related to calcium and exercise, health beliefs (based on the Health Belief Model) and self-efficacy (confidence in abilities) impact osteoprotective behaviors in epilepsy, based on the Precaution Adoption Process Model (PAPM).
View Article and Find Full Text PDF